Literature DB >> 11801306

Comparative genomic hybridization in ganglioneuroblastomas.

Ahter Dilsad Toraman1, Ibrahim Keser, Güven Lüleci, Nurdan Tunali, Tekinalp Gelen.   

Abstract

The ganglioneuroblastoma are rare lesions with widespread neuronal differentiation that have been classified as intermediate stages between neuroblastoma and ganglioneuroma. To identify overall chromosome aberrations in ganglioneuroblastoma, we performed comparative genomic hybridization. All of the five tumor samples were found to exhibit multiple gains involving different chromosomal regions. Chromosomal gains displayed by chromosomes and chromosome loci were 2p25 approximately pter (60%), 5p15.1 approximately p15.3 (60%), 7 (60%), 13q22 approximately q31 (60%), and 22 (60%), which were detected as minimal common regions in all five tumor samples. Chromosome 22 gain, which had not been reported in neuronal tumors before, and novel site 13q22 approximately q31 may be considered to play an important role in progression and differentiation of ganglioneuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801306     DOI: 10.1016/s0165-4608(01)00521-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.

Authors:  Paola Angelini; Sylvain Baruchel; Paula Marrano; Meredith S Irwin; Paul S Thorner
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

Review 2.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 3.  11q deletion in neuroblastoma: a review of biological and clinical implications.

Authors:  Vid Mlakar; Simona Jurkovic Mlakar; Gonzalo Lopez; John M Maris; Marc Ansari; Fabienne Gumy-Pause
Journal:  Mol Cancer       Date:  2017-06-29       Impact factor: 27.401

4.  DNA gains and losses of chromosome in laryngeal squamous cell carcinoma using comparative genomic hybridization.

Authors:  Ibrahim Keser; Ahter D Toraman; Gulay Ozbilim; Kenan Guney; Guven Luleci
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

5.  Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.

Authors:  Miao Wang; Chunju Zhou; Rongqin Cai; Yong Li; Liping Gong
Journal:  Diagn Pathol       Date:  2013-01-15       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.